# GeneDx Holdings Corp. (WGSWW) — capital_raise/private_placement [announced]
Source: SEC API (secapi.ai) · situation sit_e7981e3c98a96f5cfdc3 · retrieved 2026-08-11T16:10:43.803Z

## Overview
GeneDx Holdings Corp. is the leader in rare disease diagnosis and genomic data analysis, offering ExomeDx and GenomeDx tests ranked #1 by expert geneticists and granted FDA Breakthrough Device designation.

GeneDx Holdings Corp. amended and restated its existing loan agreement with Blackstone on August 3, 2026, adding a $50.0 million term loan facility and increasing the total aggregate principal amount available to $150.0 million. Concurrently, an affiliate of Blackstone purchased approximately $5.0 million of GeneDx's Class A common stock at $61.00 per share in a private placement. The combined transaction increased the company's pro forma cash position to approximately $188 million, including the existing cash, cash equivalents, marketable securities and restricted cash balance of $133.5 million as of June 30, 2026.

## Terms
- Counterparty: Blackstone · Deal value: $55.0M · Consideration: mixed · Price/share: $61

## Key dates
- Announced 2026-08-03

## Timeline
- 2026-08-03 · 8-K (0001628280-26-051852): 8-K - GeneDx Holdings Corp. — *GeneDx Holdings Corp. is the leader in rare disease diagnosis and genomic data analysis, offering ExomeDx and GenomeDx tests ranked #1 by expert geneticists and granted FDA Breakthrough Device designation.* GeneDx Holdings Corp. amended and restated its existing loan agreement with Blackstone on August 3, 2026, adding a $50.0 million term loan facility and increasing the total aggregate principal amount available to $150.0 million. Concurrently, an affiliate of Blackstone purchased approximately $5.0 million of GeneDx's Class A common stock at $61.00 per share in a private placement. The combined transaction increased the company's pro forma cash position to approximately $188 million, including the existing cash, cash equivalents, marketable securities and restricted cash balance of $133.5 million as of June 30, 2026.
  https://www.sec.gov/Archives/edgar/data/1818331/0001628280-26-051852.txt

## Citations
- 0001628280-26-051852 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000162828026051852